These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5565432)

  • 1. Propranolol in hypertension.
    Zacharias FJ; Cowen KJ
    Am Heart J; 1971 Sep; 82(3):427-8. PubMed ID: 5565432
    [No Abstract]   [Full Text] [Related]  

  • 2. Guancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol.
    Clark DW; Goldberg LI
    Ann Intern Med; 1972 Apr; 76(4):579-85. PubMed ID: 4565483
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of hypotensive effects of foridon and corinfar (results of the single-blind placebo-controlled study)].
    Shalaev SV; Igoshina LIu; Purgina GIa; Andikian TI; Gapon LI
    Kardiologiia; 1990 Dec; 30(12):59-60. PubMed ID: 2097399
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of arterial hypertension in old age].
    Cybulska I; Wasowska-Ciszek T
    Kardiol Pol; 1980; 23(6):505-8. PubMed ID: 7420818
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of propranolol on elevated arterial blood pressure.
    Richardson DW; Freund J; Gear AS; Mauck HP; Preston LW
    Circulation; 1968 Apr; 37(4):534-42. PubMed ID: 4870102
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hypertension with propranolol in combination with other antihypertensive agents].
    Dück KD
    Z Gesamte Inn Med; 1975 Nov; 30(22):727-30. PubMed ID: 1210474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between adrenergic blocking and antihypertensive effects of beta receptor antagonists.
    Rahn KH
    Adv Clin Pharmacol; 1976; 11():14-8. PubMed ID: 25567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the effectiveness of delayed-action propranolol in the treatment of arterial hypertension].
    Markiewicz M; Koziara Z; Wysokiński A; Lakomski B
    Wiad Lek; 1992 Apr; 45(7-8):243-7. PubMed ID: 1462581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic analyses of antihypertensive drugs, nifedipine and propranolol, in spontaneously hypertensive rats to investigate characteristics of effect and side effects.
    Kiriyama A; Honbo A; Nishimura A; Shibata N; Iga K
    Regul Toxicol Pharmacol; 2016 Apr; 76():21-9. PubMed ID: 26773344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of a three-drug regimen for the treatment of hypertension: hydrochlorothiazide, propranolol, and guanadrel.
    Gore RD
    Clin Ther; 1983; 6(1):86-93. PubMed ID: 6673832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive and hemodynamic effects of beta-receptor blockaders with various action spectra].
    Lohmöller G; Lydtin H; Frohlich ED
    Adv Clin Pharmacol; 1976; 11():94-8. PubMed ID: 25572
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive activity of a propranolol analog (ORF 12,592) in rodents.
    Ram N; Heilman RD; Greenslade FC
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):102-8. PubMed ID: 1015906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily treatment of hypertension.
    Br Med J; 1976 Jul; 2(6029):235. PubMed ID: 10042
    [No Abstract]   [Full Text] [Related]  

  • 15. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
    Brunner HR; Waeber B; Ferguson RK; Turini GA; Gavras H
    Cardiology; 1979; 64 Suppl 1():88-95. PubMed ID: 42489
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of propranolol in hypertension: a review.
    Hansson L
    Postgrad Med J; 1976; 52 Suppl 4():77-80. PubMed ID: 9634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal use of propranolol in portal hypertension.
    Cales P
    Gastroenterol Clin Biol; 2005 Feb; 29(2):207-8. PubMed ID: 15803523
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of patients with arterial hypertension and the ways of its optimal management (results of long-term and controlled therapy)].
    Mazur NA
    Kardiologiia; 1990 Jul; 30(7):5-7. PubMed ID: 2232463
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
    Sica D; Frishman WH; Manowitz N
    Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor antagonist propranolol potentiates hypotensive action of natriuretic peptides.
    Yoshimoto T; Naruse M; Irie K; Tanabe A; Seki T; Tanaka M; Imaki T; Naruse K; Muraki T; Matsuda Y; Demura H
    Eur J Pharmacol; 1998 Jun; 351(1):61-6. PubMed ID: 9698206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.